Skip to main content
. 2020 Aug 21;12(4):303–310. doi: 10.5114/jcb.2020.98108

Table 7.

5-year overall survival (OS) for patients divided by COMS size after propensity score matching

COMS size Brachytherapy cohort Enucleation cohort Log rank
n patients 5-year OS n patients 5-year OS
Small 355 86.5% 331 64.1% p < 0.001
Medium 628 77.1% 612 56.6% p < 0.001
Large 612 67.9% 652 45.7% p < 0.001